US & Canada Beta Glucan Market - Forecast to 2027

US & Canada Beta Glucan Market –Research Report, by product types (Yeast extract and Yeast beta), by applications (Beverages, Dairy products, Pharmaceuticals, Bakery & processed food and others (animal feed, bio feed, cosmetics) and by functionality type (Soluble beta-glucan and Insoluble beta-glucan) - Forecast to 2027

ID: MRFR/F-B & N/0218-HCR | February 2021 | Region: Global | 107 pages

US & Canada Beta Glucan Market Scenario


US & Canada Beta Glucan Market will register the CAGR of more than 6.1% during the forecast period.


Developing interest for nutraceutical and functional product is found in the most recent decade. This happened because of quick way of life and idea of curing illness through food. Individuals everywhere throughout the world have a mission for new choices and idea of functional ingredients fulfill their dietary needs as these positively affect metabolic parameters and eventually supportive in diseases, for example, cancer, diabetes and cardiovascular disease. Beta Glucan is a significant functional ingredient that has various medical advantages. Its part in controlling hyperlipedemia and hyperglycemia is unprecedented.

The general purpose of beta glucan is to enhance and improve the human immune system. Currently, people are getting more aware and conscious about health food intake and boost their immune system, while performing these activities the demand of Beta-Glucan has increased globally.

The global beta glucan industry reached US$ XX Million in 2016, marking an annual increase of 15% from 2014, majorly driven by increase in nutritional supplements. Globally, Western Europe (France, Spain, Italy, U.K, Germany and others) dominates the beta glucan industry, while North America is the second largest market for beta glucan industry. In North America, the US acquires the greater part of the beta-glucan market and captures XX% of the market as compared to Canada. The US market was estimnated US$ XX Million in 2014 and is anticipated to reach US$ XX Million in 2016. Population growth, green movement large immigrants, urbanization, health awareness, , increase in middle class population will compel growth in the beta glucan market in the US. As per MRFR analysis, more than 100 manufacturers are manufacturing beta glucan in the US.

Key Players
The prominent players present in the US & Canada Beta Glucan Market includes Lesaffre USA, DSM USA, Bio Springer, Lallemand, Associated British Foods, Biothera Inc, Tate & Lyle, Garuda International Inc, Alltech, Ceapro Inc, Super Beta glucan, ConAgra Foods, Inc, Cargill and others.

The strategy adopted by DSM is that working with its own clients and customers to create awareness and mindfulness amongst customers of the advantages of oat beta-glucan and the Friend OatWell brand has been created to convey the advantages on buyer product bundling. OatWell is accessible in flour or powder design, reasonable for use in applications running from breads, biscuits and oats to pasta, refreshments, instant powder drinks and dietary supplements. The other players’ strategies are also discussed in the report.

Research Methodology

To calculate US & Canada beta glucan market size, MRFR has considered prominent players in the in the US & Canada market and to offer accuracy, our research is supported by industry experts who offer insight on industry structure and technology assessment, competitive landscape, penetration, emerging products and trends. MRFR analysis is based (80 to 85%) on primary & (15 to 20%) on secondary research as well as years of professional expertise in their respective industries. In addition to analyze current and historical trends, our analysts predict where the market is headed over the next forecasted years. It varies by segment for these categories geographically presented in the list of market tables. Top-down and bottom-up are important strategies of processing the information and knowledge ordering, used in a variety of fields including humanistic, software and scientific theories and management and organization. In practice, they can be seen as a style of thinking, teaching, or leadership.


 

 

 

 

 

Source: Market Research Future Analysis

Speaking about this particular report we have conducted primary surveys(interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.

Scope of the Report

This market research report covers the US & Canada Beta Glucan Market research report which has been segment as:

On the basis of Geographical Regions


  • North America

    • The US

    • Canada





Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.1% (2016-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Types, Applications, Functionality Type
  Geographies Covered   US & Canada
  Key Vendors   Lesaffre USA, DSM USA, Bio Springer, Lallemand, Associated British Foods, Biothera Inc, Tate & Lyle, Garuda International Inc, Alltech, Ceapro Inc, Super Beta glucan, ConAgra Foods, Inc, Cargill
  Key Market Opportunities   Increase in middle class population
  Key Market Drivers

  • Urbanization
  • Health Awareness


  • Frequently Asked Questions (FAQ) :


    The general purpose of beta glucan is to enhance and improve the human immune system. Beta glucans are sugar compounds found in bacteria, yeast, fungi, algae and plants such as oats and barley.

    The market is expected to exhibit a strong 6.1% CAGR over the forecast period from 2020 to 2027.

    Key players in the market include Lesaffre USA, DSM USA, Bio Springer, Lallemand, Associated British Foods, Biothera Inc, Tate & Lyle, Garuda International Inc, Alltech, Ceapro Inc, Super Beta glucan, ConAgra Foods, Inc, Cargill and others.

    THE US & CANADA BETA GLUCAN MARKET

    1. INTRODUCTION

    1.1 DEFINITION

    1.2 SCOPE OF THE STUDY

    1.2.1 RESEARCH OBJECTIVE

    1.2.2 ASSUMPTIONS

    1.2.3 LIMITATIONS

    1.3 MARKET STRUCTURE

    2. RESEARCH METHODOLOGY

    2.1 RESEARCH PROCESS

    2.2 PRIMARY RESEARCH

    2.3 SECONDARY RESEARCH

    2.4 MARKET SIZE ESTIMATION

    2.5 FORECAST MODEL

    3. THE US & CANADA BETA GLUCAN MARKET: OVERVIEW

    3.1 INTRODUCTION OF BETA GLUCAN MARKET

    3.1.1 DEFINITION OF BETA GLUCAN MARKET

    3.1.2 MARKET SEGMENTATION OF BETA GLUCAN MARKET

    3.1.2.1 MARKET SEGMENTATION ON THE BASIS OF PRODUCT TYPES

    3.1.2.2 MARKET SEGMENTATION ON THE BASIS OF APPLICATION

    3.1.2.3 MARKET SEGMENTATION ON THE BASIS OF FUNCTIONALITY TYPE

    4. MARKET DYNAMICS

    4.1 DRIVERS

    4.1.1 INCREASING AWARENESS AND HEALTH CONSCIOUSNESS

    4.2 RESTRAINTS

    4.2.1 LACK OF AWARENESS REGARDING CONSUMPTION

    4.3 OPPORTUNITIES

    4.3.1 INCREASING DEMAND OF PROCESSED FOOD

    4.4 MEGA TRENDS

    4.4.1 RISING AWARENESS AND CHANDING LIFE STYLE

    4.5 MACROECONOMIC INDICATORS

    4.7 IMPORTANT POINTERS BY INDUSTRY EXPERTS

    5. THE US & CANADA BETA GLUCAN MARKET: VALUE/SUPPLY CHAIN ANALYSIS

    6. THE US & CANADA BETA GLUCAN MARKET: PORTER'S 5 FORCES ANALYSIS

    6.1 THREAT OF NEW ENTRANTS

    6.2 THREAT OF SUBSTITUTES

    6.3 BARGAINING POWER OF BUYERS/CUSTOMER

    6.4 BARGAINING POWER OF SUPPLIERS

    6.5 DEGREE OF COMPETITION

    7. THE US & CANADA BETA GLUCAN MARKET: MARKET VALUE & VOLUME FORECAST (2016-2027) (US $ MILLION)

    7.1 Y-O-Y GROWTH PROJECTIONS

    7.2 OPPORTUNITY ANALYSIS

    7.3 MARKET SHARE ANALYSIS

    8. THE US & CANADA BETA GLUCAN MARKET: BY PRODUCT TYPES

    8.1 INTRODUCTION

    8.2 Y-O-Y GROWTH PROJECTIONS BY PODUCT TYPES

    8.3 MARKET SIZE BY PRODUCT TYPES

    8.3.1 PATHOGENS

    8.3.1.1 YEAST EXTRACT

    8.3.1.2 YEAST BETA

    9. THE US & CANADA BETA GLUCAN MARKET: BY APPLICATIONS

    9.1 INTRODUCTION

    9.2 Y-O-Y GROWTH PROJECTIONS BY APPLICATIONS

    9.3 MARKET SIZE BY APPLICATIONS

    9.3.1 BEVERAGES

    9.3.2 DAIRY PRODUCTS

    9.3.3 PHARMACEUTICALS

    9.3.4 BAKERY & PROCESSED

    9.3.5 OTHER (ANIMAL FEED, BIO FEED AND COSMETICS)

    10. THE US & CANADA BETA GLUCAN MARKET: BY FUNCTIONALITY TYPE

    10.1 INTRODUCTION

    10.2 Y-O-Y GROWTH PROJECTIONS BY FUNCTIONALITY TYPE

    10.3 MARKET SIZE BY FUNCTIONALITY TYPE

    10.3.1 SOLUBLE BETA-GLUCAN

    10.3.2 INSOLUBLE BETA-GLUCAN

    11. THE US & CANADA BETA GLUCAN MARKET: BY COUNTRY

    11.1 INTRODUCTION

    11.2 Y-O-Y GROWTH PROJECTIONS BY COUNTRY

    11.3 MARKET SIZE BY REGION

    11.3.1 NORTH AMERICA

    11.3.1.1 THE US

    11.3.1.2 CANADA

    12. COMPANY LANDSCAPE

    12.1 INTRODUCTION: KEY PLAYERS

    12.3 MARKET SHARE ANALYSIS

    13. COMPANY PROFILE

    13.1 LESAFFRE USA

    13.1.1 COMPANY OVERVIEW

    13.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.1.3 GEOGRAPHICAL PRESENCE

    13.1.4 FINANCIAL UPDATES

    13.1.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.1.6 KEY CUSTOMERS

    13.1.7 KEY DEVELOPMENTS

    13.1.8 CONTACT INFORMATION

    13.2 DSM USA

    13.2.1 COMPANY OVERVIEW

    13.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.2.3 GEOGRAPHICAL PRESENCE

    13.2.4 FINANCIAL UPDATES

    13.2.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.2.6 KEY CUSTOMERS

    13.2.7 KEY DEVELOPMENTS

    13.2.8 CONTACT INFORMATION

    13.3 BIO SPRINGER

    13.3.1 COMPANY OVERVIEW

    13.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.3.3 GEOGRAPHICAL PRESENCE

    13.3.4 FINANCIAL UPDATES

    13.3.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.3.6 KEY CUSTOMERS

    13.3.7 KEY DEVELOPMENTS

    13.3.8 CONTACT INFORMATION

    13.4 LALLEMAND

    13.4.1 COMPANY OVERVIEW

    13.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.4.3 GEOGRAPHICAL PRESENCE

    13.4.4 FINANCIAL UPDATES

    13.4.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.4.6 KEY CUSTOMERS

    13.4.7 KEY DEVELOPMENTS

    13.4.8 CONTACT INFORMATION

    13.5 ASSOCIATED BRITISH FOODS

    13.5.1 COMPANY OVERVIEW

    13.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.5.3 GEOGRAPHICAL PRESENCE

    13.5.4 FINANCIAL UPDATES

    13.5.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.5.6 KEY CUSTOMERS

    13.5.7 KEY DEVELOPMENTS

    13.5.8 CONTACT INFORMATION

    13.6 BIOTHERA INC

    13.6.1 COMPANY OVERVIEW

    13.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.6.3 GEOGRAPHICAL PRESENCE

    13.6.4 FINANCIAL UPDATES

    13.6.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.6.6 KEY CUSTOMERS

    13.6.7 KEY DEVELOPMENTS

    13.6.8 CONTACT INFORMATION

    13.7 TATE & LYLE

    13.7.1 COMPANY OVERVIEW

    13.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.7.3 GEOGRAPHICAL PRESENCE

    13.7.4 FINANCIAL UPDATES

    13.7.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.7.6 KEY CUSTOMERS

    13.7.7 KEY DEVELOPMENTS

    13.7.8 CONTACT INFORMATION

    13.8 GARUDA INTERNATIONAL INC

    13.8.1 COMPANY OVERVIEW

    13.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.8.3 GEOGRAPHICAL PRESENCE

    13.8.4 FINANCIAL UPDATES

    13.8.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.8.6 KEY CUSTOMERS

    13.8.7 KEY DEVELOPMENTS

    13.8.8 CONTACT INFORMATION

    13.9 ALLTECH

    13.9.1 COMPANY OVERVIEW

    13.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.9.3 GEOGRAPHICAL PRESENCE

    13.9.4 FINANCIAL UPDATES

    13.9.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.9.6 KEY CUSTOMERS

    13.9.7 KEY DEVELOPMENTS

    13.9.8 CONTACT INFORMATION

    13.10 CEAPRO INC

    13.10.1 COMPANY OVERVIEW

    13.10.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.10.3 GEOGRAPHICAL PRESENCE

    13.10.4 FINANCIAL UPDATES

    13.10.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.10.6 KEY CUSTOMERS

    13.10.7 KEY DEVELOPMENTS

    13.10.8 CONTACT INFORMATION

    13.11 SUPER BETA GLUCAN

    13.11.1 COMPANY OVERVIEW

    13.11.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.11.3 GEOGRAPHICAL PRESENCE

    13.11.4 FINANCIAL UPDATES

    13.11.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.11.6 KEY CUSTOMERS

    13.11.7 KEY DEVELOPMENTS

    13.11.8 CONTACT INFORMATION

    13.12 CONAGRA FOODS

    13.12.1 COMPANY OVERVIEW

    13.12.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.12.3 GEOGRAPHICAL PRESENCE

    13.12.4 FINANCIAL UPDATES

    13.12.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.12.6 KEY CUSTOMERS

    13.12.7 KEY DEVELOPMENTS

    13.12.8 CONTACT INFORMATION

    13.13 CARGILL

    13.13.1 COMPANY OVERVIEW

    13.13.2 PRODUCT/BUSINESS SEGMENT OVERVIEW

    13.13.3 GEOGRAPHICAL PRESENCE

    13.13.4 FINANCIAL UPDATES

    13.13.5 KEY ACQUISITIONS-REASONS & STRATEGY

    13.13.6 KEY CUSTOMERS

    13.13.7 KEY DEVELOPMENTS

    13.13.8 CONTACT INFORMATION